Regulation of CDK7-Carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation

Molecular and Cellular Biology

Volumn 20, Issue 20, 2000, Pages 7726-7734

  Nishiwaki, E ^a   Turner, S L ^a   Harju, S ^a   Miyazaki, S ^a   Kashiwagi, M ^a   Koh, J ^a   Serizawa, H ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; PROTEIN KINASE; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CARRIER PROTEINS; CELL CYCLE; CHIMERIC PROTEINS; CYCLIN-DEPENDENT KINASES; CYCLINS; FLOW CYTOMETRY; HELA CELLS; HUMAN; MACROMOLECULAR SYSTEMS; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN P16; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; SEQUENCE ALIGNMENT; SUPPORT, NON-U.S. GOV'T; TRANSCRIPTION FACTORS;

EID: 0033796319     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.20.7726-7734.2000     Document Type: Article

References (41)

1. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas
2. Ten years of TFIIH
3. General initiation factors for RNA polymerase II
4. Tails of RNA polymerase II
5. The role of multisite phosphorylation in the regulation of RNA polymerase II activity
6. MAT1 ('menage a trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK
7. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK
8. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase
9. Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A
10. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
11. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest
12. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age
13. Germline p16 mutations in familial melanoma
14. A cell cycle regulator potentially involved in genesis of many tumor types
15. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
16. The RNA polymerase II holoenzyme and its implications for gene regulation
17. Cdk7 is essential for mitosis and for in vivo Cdk-activating kinase activity
18. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
19. CDKN2A mutations in multiple primary melanomas
20. Principles of CDK regulation
21. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
22. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor
23. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
24. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH
25. Association of Cdk-activating kinase subunits with transcription factor TFIIH
26. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
27. Cancer cell cycles
28. Cdk-activating kinase complex is a component of human transcription factor TFIIH
29. The function(s) of CAK, the p34cdc2-activating kinase
30. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group
31. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein
32. Tumor suppressor p16INK4A: Structural characterization of wild-type and mutant proteins by NMR and circular dichroism
33. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
34. The KIN28 gene is required both for RNA polymerase II mediated transcription and phosphorylation of the Rpb1p CTD
35. The retinoblastoma protein and cell cycle control
36. Mutational effects on the p16INK4a tumor suppressor protein
37. Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors
38. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors
39. Common themes in assembly and function of eukaryotic transcription complexes
40. Growth suppression by members of the retino-blastoma protein family